237 related articles for article (PubMed ID: 23016758)
1. Novel antimicrobial agents against multi-drug-resistant gram-positive bacteria: an overview.
Giannakaki V; Miyakis S
Recent Pat Antiinfect Drug Discov; 2012 Dec; 7(3):182-8. PubMed ID: 23016758
[TBL] [Abstract][Full Text] [Related]
2. Novel antimicrobial agents against multi-drug-resistant gram-negative bacteria: an overview.
Karras G; Giannakaki V; Kotsis V; Miyakis S
Recent Pat Antiinfect Drug Discov; 2012 Dec; 7(3):175-81. PubMed ID: 23061790
[TBL] [Abstract][Full Text] [Related]
3. Novel agents for resistant Gram-positive infections--a review.
Strahilevitz J; Rubinstein E
Int J Infect Dis; 2002 Mar; 6 Suppl 1():S38-46. PubMed ID: 12044288
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Manfredi R
Recenti Prog Med; 2007 Mar; 98(3):143-54. PubMed ID: 17484159
[TBL] [Abstract][Full Text] [Related]
5. Resistance mechanisms of gram-positive bacteria.
Berger-Bächi B
Int J Med Microbiol; 2002 Jun; 292(1):27-35. PubMed ID: 12139425
[TBL] [Abstract][Full Text] [Related]
6. Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci.
Rivera AM; Boucher HW
Mayo Clin Proc; 2011 Dec; 86(12):1230-43. PubMed ID: 22134942
[TBL] [Abstract][Full Text] [Related]
7. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
Dowzicky MJ
Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
[TBL] [Abstract][Full Text] [Related]
9. [Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].
Jankowski A; Stefanik W
Wiad Lek; 2006; 59(9-10):727-31. PubMed ID: 17338140
[TBL] [Abstract][Full Text] [Related]
10. Novel antibacterial agents for the treatment of serious Gram-positive infections.
Abbanat D; Macielag M; Bush K
Expert Opin Investig Drugs; 2003 Mar; 12(3):379-99. PubMed ID: 12605562
[TBL] [Abstract][Full Text] [Related]
11. Gram-positive resistance: pathogens, implications, and treatment options: insights from the Society of Infectious Diseases Pharmacists.
Akins RL; Haase KK
Pharmacotherapy; 2005 Jul; 25(7):1001-10. PubMed ID: 16006278
[TBL] [Abstract][Full Text] [Related]
12. Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential.
Rubinstein E; Bompart F
J Antimicrob Chemother; 1997 May; 39 Suppl A():139-43. PubMed ID: 9511078
[TBL] [Abstract][Full Text] [Related]
13. Fighting infections due to multidrug-resistant Gram-positive pathogens.
Cornaglia G
Clin Microbiol Infect; 2009 Mar; 15(3):209-11. PubMed ID: 19335367
[TBL] [Abstract][Full Text] [Related]
14. An overview of antimicrobial susceptibility patterns of gram-positive bacteria from National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005.
Mootsikapun P; Trakulsomboon S; Sawanpanyalert P; Aswapokee N; Suankratay C
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S87-90. PubMed ID: 21294504
[TBL] [Abstract][Full Text] [Related]
15. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.
Cornaglia G; Rossolini GM
Clin Microbiol Infect; 2009 Mar; 15(3):218-23. PubMed ID: 19335369
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance in gram-positive bacteria.
Rice LB
Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
[TBL] [Abstract][Full Text] [Related]
17. Tigecycline: first of a new class of antimicrobial agents.
Rose WE; Rybak MJ
Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance in gram-positive bacteria.
Rice LB
Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S11-9; discussion S64-73. PubMed ID: 16813977
[TBL] [Abstract][Full Text] [Related]
19. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
Napolitano LM
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
[TBL] [Abstract][Full Text] [Related]
20. Current and future challenges in the development of antimicrobial agents.
Rennie RP
Handb Exp Pharmacol; 2012; (211):45-65. PubMed ID: 23090595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
